Serum interleukin-18 in patients with chronic ordinary urticaria: Association with disease activity

A. Tedeschi, M. Lorini, C. Suli, R. Asero

Research output: Contribution to journalArticlepeer-review

Abstract

Interleukin (IL)-18 is a pleiotropic cytokine, which may play a role in autoimmune and allergic disorders. Serum IL-18 levels were measured in 34 patients with chronic ordinary urticaria (COU) and 17 normal subjects. In vivo and in vitro assays for histamine-releasing factors, an autologous serum skin test (ASST) and a basophil histamine release assay were also performed for all patients with COU. Serum IL-18 concentration was not significantly different between patients with COU and normal subjects (mean ± standard error of the mean 246.47 ± 18.40 pg/mL vs. 213.88 ± 22.24 pg/mL), and no significant difference was found between ASST-positive and ASST-negative patients. However, in ASST-positive patients, IL-18 levels paralleled clinical severity scores and showed a tendency to correlate with in vitro histamine release. The increased IL-18 levels in the ASST-positive patients with most active chronic urticaria may reflect stronger immune system activation and possibly an involvement of IL-18 as a direct histamine-releasing factor.

Original languageEnglish
Pages (from-to)568-570
Number of pages3
JournalClinical and Experimental Dermatology
Volume32
Issue number5
DOIs
Publication statusPublished - Sep 2007

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Serum interleukin-18 in patients with chronic ordinary urticaria: Association with disease activity'. Together they form a unique fingerprint.

Cite this